Form 4: Butterfly Network Executive Receives 2 Million Restricted Stock Units

Steve Cashman, Chief Business Officer of Butterfly Network, acquires 2,000,000 restricted stock units (RSUs) in company stock.

Summary

• Steve Cashman, the Chief Business Officer of Butterfly Network, has acquired a total of 2,000,000 shares of Class A Common Stock in the form of restricted stock units (RSUs).
• 1,000,000 of these RSUs will vest over three years, with one-third vesting on September 3, 2025, and the remainder vesting pro rata annually, contingent upon continued service.
• The other 1,000,000 performance-based RSUs will vest in thirds upon the achievement of stock prices of $2.00, $3.00, and $4.00 per share, respectively, for 20 consecutive trading days before September 3, 2029, also contingent upon continued service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of RSUs is a standard practice, and the performance-based component suggests confidence in the company's future prospects. However, it's not overwhelmingly positive as it's a routine disclosure.

Positives

• The vesting of performance-based RSUs is tied to achieving specific stock price targets, which could incentivize management to drive company performance and increase shareholder value.
• The vesting schedule encourages continued service of the Chief Business Officer.

Risks

• The performance-based RSUs may not vest if the stock price targets are not met before September 3, 2029.
• The vesting of all RSUs is contingent upon the Reporting Person's continued service, creating a potential risk if the Reporting Person leaves the company.

Future Outlook

The vesting of the performance-based RSUs is contingent on achieving certain stock price targets by September 3, 2029, which could influence the company's strategic decisions and focus on increasing shareholder value.

Industry Context

Stock grants to executives are a common practice in the tech and healthcare industries to align management's interests with those of shareholders. The use of performance-based RSUs is intended to further incentivize executives to achieve specific financial or operational goals.

Comparison to Industry Standards

• Companies like Teladoc Health and Intuitive Surgical also use a mix of time-based and performance-based equity awards for their executives.
• The specific vesting criteria and stock price targets are tailored to Butterfly Network's growth strategy and market conditions.
• The size of the grant is comparable to grants made to executives at similar-sized companies in the medical device industry.

Stakeholder Impact

• Shareholders may view the performance-based RSUs positively, as they align management's interests with increasing shareholder value.
• Employees may be motivated by the potential for the company to achieve its stock price targets.
• The grant of RSUs has no immediate impact on customers, suppliers, or creditors.

Key Dates